Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.06
+0.32 (4.75%)
At close: Jun 6, 2025, 4:00 PM
7.07
+0.01 (0.14%)
After-hours: Jun 6, 2025, 7:41 PM EDT

Trevi Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
718368861162044
Upgrade
Market Cap Growth
155.61%330.28%-26.01%472.04%-54.55%-33.49%
Upgrade
Enterprise Value
616304-2165
Upgrade
Last Close Price
7.064.121.341.930.782.42
Upgrade
PB Ratio
7.093.701.041.081.181.63
Upgrade
P/TBV Ratio
7.223.701.041.081.181.63
Upgrade
Debt / Equity Ratio
0.010.010.020.090.860.52
Upgrade
Quick Ratio
15.1110.2914.338.992.908.10
Upgrade
Current Ratio
15.3810.4115.039.152.988.33
Upgrade
Return on Equity (ROE)
-55.12%-52.59%-30.59%-46.82%-153.03%-80.07%
Upgrade
Return on Assets (ROA)
-34.41%-32.15%-19.96%-23.15%-47.42%-37.91%
Upgrade
Return on Capital (ROIC)
-36.70%-34.90%-21.15%-25.18%-55.37%-42.13%
Upgrade
Earnings Yield
-6.59%-13.01%-33.97%-25.21%-167.88%-73.64%
Upgrade
FCF Yield
-5.75%-10.40%-37.22%-24.50%-143.18%-65.27%
Upgrade
Buyback Yield / Dilution
-7.29%-2.97%-53.44%-182.56%-26.48%-53.88%
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q